Marinus Pharmaceuticals, Inc. (MRNS) SEC filings
MRNS SEC filings moved a median of +0.85% by the close. MRNS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the MRNS overview →
34 measured MRNS SEC filing events.
Where these MRNS SEC filings landedvs 29 measured MRNS SEC filing reactions
| Middle 50% of MRNS SEC filing reactions | -2.84% to +2.01% |
|---|---|
| Median reaction (to close) | +0.85% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 MRNS SEC filing events with a measured close landed between -2.84% and +2.01%; 59% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G MARINUS PHARMACEUTICALS, | SEC filing · Form 15-12G | — | — | |
| Form EFFECT MARINUS PHARMACEUTICALS, | SEC filing · Form EFFECT | — | — | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Feb 07 | SEC filing · Form 8-K | — | — | |
| Form POS AM MARINUS PHARMACEUTICALS, | SEC filing · Form POS | — | — | |
| Form S-8 POS MARINUS PHARMACEUTICALS, | SEC filing · Form S-8 | — | — | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Dec 23 | SEC filing · Form 8-K | +0.35% | +1.17% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Dec 29 | SEC filing · Form 8-K | +0.35% | +1.17% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Dec 17 | SEC filing · Form 8-K | +1.28% | +9.91% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Dec 06 | SEC filing · Form 8-K | +0.00% | +4.29% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Nov 14 | SEC filing · Form 8-K | -2.48% | -2.65% | |
| Form 10-Q MARINUS PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -5.84% | -10.40% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Nov 12 | SEC filing · Form 8-K | -5.84% | -10.40% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Oct 24 | SEC filing · Form 8-K | +2.65% | -39.59% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Oct 02 | SEC filing · Form 8-K | +0.59% | +1.19% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Sep 20 | SEC filing · Form 8-K | -1.24% | +2.47% | |
| Form 10-Q MARINUS PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.85% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Aug 13 | SEC filing · Form 8-K | +0.00% | +0.85% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Jun 17 | SEC filing · Form 8-K | +5.04% | +4.32% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Jun 06 | SEC filing · Form 8-K | -0.34% | +2.01% | |
| Form S-8 MARINUS PHARMACEUTICALS, | SEC filing · Form S-8 | -0.34% | +2.01% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: May 22 | SEC filing · Form 8-K | -0.56% | +5.34% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: May 17 | SEC filing · Form 8-K | +2.31% | +2.31% | |
| Form 10-Q MARINUS PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +3.85% | -8.33% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: May 08 | SEC filing · Form 8-K | +3.85% | -8.33% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Apr 15 | SEC filing · Form 8-K | +2.21% | -29.73% | |
| Form DEF 14A MARINUS PHARMACEUTICALS, For: May 22 | SEC filing · Form DEF | -0.91% | -1.25% | |
| Form DEFA14A MARINUS PHARMACEUTICALS, | SEC filing · Form DEFA14A | -0.91% | -1.25% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Mar 27 | SEC filing · Form 8-K | +1.01% | +1.46% | |
| Form 10-K MARINUS PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | -7.21% | +0.22% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Mar 05 | SEC filing · Form 8-K | -7.21% | +0.22% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Jan 04 | SEC filing · Form 8-K | +9.64% | +7.90% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Nov 28 | SEC filing · Form 8-K | -2.09% | -0.63% | |
| Form 10-Q MARINUS PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -1.34% | -2.84% | |
| Form 8-K MARINUS PHARMACEUTICALS, For: Nov 07 | SEC filing · Form 8-K | -1.34% | -2.84% |
Keep exploring
More MRNS: earnings → · analyst actions → · MRNS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Teva Pharmaceutical Industries Limited (TEVA) | 692 | -0.06% | 49% |
| Tyme Technologies, Inc. (TYME) | 691 | -0.28% | 41% |
| PTC Therapeutics, Inc. (PTCT) | 686 | +0.01% | 50% |
| Gilead Sciences, Inc. (GILD) | 677 | -0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.